Some drugs can actually improve cognitive function, scientists have demonstrated. This finding may have implications for our understanding of disorders like Alzheimer's disease.
The study, led by Jose A. Esteban, Shira Knafo and Cesar Venero, is the result of collaboration between researchers from The Centro de BiologĦa Molecular Severo Ochoa and UNED (Spain), the Brain Mind Institute (EPFL, Switzerland) and the Department of Neuroscience and Pharmacology (Faculty of Health Sciences, Denmark).
The human brain contains trillions of neuronal connections, called synapses, whose pattern of activity controls all our cognitive functions. These synaptic connections are dynamic and constantly changing in their strength and properties.
The study by Knafo et al. provides new information on the molecular mechanisms of synaptic plasticity, and how this process may be manipulated to improve cognitive performance.
They find that synapses can be made more plastic by using a small protein fragment (peptide) derived from a neuronal protein involved in cell-to-cell communication. This peptide (called FGL) initiates a cascade of events inside the neuron that results in the facilitation of synaptic plasticity.
Specifically, the authors found that FGL triggers the insertion of new neurotransmitter receptors into synapses in a region of the brain called the hippocampus, which is known to be involved in multiple forms of learning and memory.
Importantly, when this peptide was administered to rats, their ability to learn and retain spatial information was enhanced.
"We have known for three decades that synaptic connections are not fixed from birth, but they respond to neuronal activity modifying their strength. Thus, outside stimuli will lead to the potentiation of some synapses and the weakening of others. It is precisely this code of ups and downs what allows the brain to store information and form memories during learning," Esteban said.
Within this framework, these new findings demonstrate that synaptic plasticity mechanisms can be manipulated pharmacologically in adult animals, with the aim of enhancing cognitive ability.
"These are basic studies on the molecular and cellular processes that control our cognitive function. Nevertheless, they shed light into potential therapeutic avenues for mental disorders where these mechanisms go awry," Knafo said.
The study has been published in the open-access journal PLoS Biology.